Efficacy and safety of stem cell therapy for Crohn’s disease: a meta-analysis of randomized controlled trials
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Efficacy and safety of stem cell therapy for Crohn’s disease: a meta-analysis of randomized controlled trials ; volume:15 ; number:1 ; day:2 ; month:2 ; year:2024 ; pages:1-16 ; date:12.2024
Stem cell research & therapy ; 15, Heft 1 (2.2.2024), 1-16, 12.2024
- Creator
-
Qiu, Yunfeng
Li, Changfeng
Sheng, Shihou
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13287-024-03637-z
- URN
-
urn:nbn:de:101:1-2024041215420699078145
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Qiu, Yunfeng
- Li, Changfeng
- Sheng, Shihou
- SpringerLink (Online service)
Other Objects (12)
Systematic review with meta-analysis: the efficacy and safety of stem cell therapy for Crohn’s disease
Efficacy of stem cells therapy for Crohn’s fistula: a meta-analysis and systematic review
Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn’s Disease Patients Stratified by Age
Efficacy, drug sustainability, and safety of ustekinumab treatment in Crohn’s disease patients over three years
Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn’s disease and ulcerative colitis included in randomised controlled trials
Crohn’s appendicitis
Esophageal Crohn’s disease
Efficacy and safety of adalimumab in pediatric patients with Crohn’s disease: A systematic review and meta-analysis
Efficacy of early immunomodulator therapy on the outcomes of Crohn’s disease
Efficacy and safety of allogeneic umbilical cord-derived mesenchymal stem cells for the treatment of complex perianal fistula in Crohn’s disease: a pilot study
Efficacy of Infliximab for the Treatment of Oral Manifestation of Crohn’s Disease
Efficacy, Safety, Patient Experience, and Tolerability of Risankizumab Administered by On-Body Injector for Moderate to Severe Crohn’s Disease
Systematic review with meta-analysis: the efficacy and safety of stem cell therapy for Crohn’s disease
Efficacy of stem cells therapy for Crohn’s fistula: a meta-analysis and systematic review
Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn’s Disease Patients Stratified by Age
Efficacy, drug sustainability, and safety of ustekinumab treatment in Crohn’s disease patients over three years
Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn’s disease and ulcerative colitis included in randomised controlled trials
Crohn’s appendicitis
Esophageal Crohn’s disease
Efficacy and safety of adalimumab in pediatric patients with Crohn’s disease: A systematic review and meta-analysis
Efficacy of early immunomodulator therapy on the outcomes of Crohn’s disease
Efficacy and safety of allogeneic umbilical cord-derived mesenchymal stem cells for the treatment of complex perianal fistula in Crohn’s disease: a pilot study
Efficacy of Infliximab for the Treatment of Oral Manifestation of Crohn’s Disease
Efficacy, Safety, Patient Experience, and Tolerability of Risankizumab Administered by On-Body Injector for Moderate to Severe Crohn’s Disease
Systematic review with meta-analysis: the efficacy and safety of stem cell therapy for Crohn’s disease
Efficacy of stem cells therapy for Crohn’s fistula: a meta-analysis and systematic review
Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn’s Disease Patients Stratified by Age
Efficacy, drug sustainability, and safety of ustekinumab treatment in Crohn’s disease patients over three years
Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn’s disease and ulcerative colitis included in randomised controlled trials
Crohn’s appendicitis
Esophageal Crohn’s disease
Efficacy and safety of adalimumab in pediatric patients with Crohn’s disease: A systematic review and meta-analysis
Efficacy of early immunomodulator therapy on the outcomes of Crohn’s disease
Efficacy and safety of allogeneic umbilical cord-derived mesenchymal stem cells for the treatment of complex perianal fistula in Crohn’s disease: a pilot study
Efficacy of Infliximab for the Treatment of Oral Manifestation of Crohn’s Disease